Outcomes4Me Aims to be ChatGPT for Cancer Care

"Data shows that 20% of patients today are getting the wrong treatment in oncology. So when we're talking about that starting base, there's a lot of willingness to try new things.” - Maya Said, CEO of Outcomes4Me

The Boston-based AI cancer care app Outcomes4Me just raised $21 million in funding, led by Salica Investments and joined by major players like Labcorp Venture Fund and Forecast Labs, bringing its total capital to $38 million. This raises an important question: can an app really change the cancer care experience?

For Dr. Maya Said, founder and CEO of Outcomes4Me, the answer is rooted in personal experience. “I had a health scare. And from one day to the other, I found myself to be a patient,” Said shared in an interview with The Health Pulse podcast. Despite being a scientist and healthcare executive, she struggled to make sense of her care options. “That time in between ‘something is suspicious’ to the time of final diagnosis, and then how to manage it was deeply overwhelming in ways I never anticipated... This is what led us to start Outcomes4Me.”

Outcomes4Me was designed to provide cancer patients with tools to understand their diagnosis, track symptoms, explore treatment options, access clinical trials, and connect with support services. It uses AI to turn complex clinical guidelines, such as those from the National Comprehensive Cancer Network (NCCN), into plain-language.